Not to be initiated or continued to prevent CHD. Increased risk of MI, pulmonary embolism, invasive breast & ovarian cancer; CV risk, stroke, VTE; endometrial, breast & ovarian cancer; dementia; gallbladder disease; hypercalcemia; angioedema; fluid retention, cardiac dysfunction; preexisting hypertriglyceridemia; elevated BP; exacerbation of asthma, epilepsy, migraine w/ or w/o aura, otosclerosis, porphyria, SLE, hepatic hemangiomas, endometriosis; hypocalcemia, hypothyroidism; impaired glucose tolerance. Palliative therapy in men. History of cholestatic jaundice; hepatic impairment. Renal dysfunction. Not to be used during pregnancy & lactation. Childn. Elderly >65 yr.